Тромбоэмболия легочной артерии: клинические рекомендации Европейского общества кардиологов (2014). По материалам: 2014 ESC Guidelines on the diagnosis andmanagement of acute pulmonary embolism – web addenda. The Task Force for the Diagnosis and Management
https://doi.org/10.18093/0869-0189-2015-25-5-525-552
Аннотация
В данных Клинических рекомендациях суммированы все современные доказательства по диагностике и лечению тромбоэмболии легочной артерии (ТЭЛА). В отличие от предыдущей версии рекомендаций, в данном документе представлены упрощенные варианты клинических прогностических шкал, подробно рассмотрена стратификация риска летального исхода, включая промежуточные степени риска, представлены новые подходы к АКТ, в т. ч. системному тромболизису и катетерным методам лечения, терапии антагонистом витамина К, определено место новых пероральных антикоагулянтов в терапии ТЭЛА.
Список литературы
1. Heit J.A. The epidemiology of venous thromboembolism in the community. Arterioscler. Thromb. Vasc. Biol. 2008; 28 (3): 370–372.
2. Cohen A.T., Agnelli G., Anderson F.A. et al. Venous throm
3. boembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb. Haemost. 2007; 98 (4): 756–764.
4. Klok F.A., van Kralingen K.W., van Dijk A.P. et al. Quality of life in longterm survivors of acute pulmonary embolism. Chest. 2010; 138 (6): 1432–1440.
5. Bonderman D., Wilkens H., Wakounig S. et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur. Respir. J. 2009; 33 (2): 325–331.
6. Condliffe R., Kiely D.G., Gibbs J.S. et al. Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension. Eur. Respir. J. 2009; 33 (2): 332–338.
7. Fanikos J., Piazza G., Zayaruzny M., Goldhaber S.Z. Longterm complications of medical patients with hospital acquired venous thromboembolism. Thromb. Haemost. 2009; 102 (4): 688–693.
8. Stein P.D., Henry J.W. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest. 1995; 108 (4): 978–981.
9. Heit J.A. III, Silverstein M.D., Mohr D.N. et al. Risk factors for deep vein thrombosis and pulmonary embolism: a populationbased casecontrol study. Arch. Intern. Med. 2000; 160 (6): 809–815.
10. Anderson F.A. Jr, Spencer F.A. Risk factors for venous throm boembolism. Circulation. 2003; 107 (23, Suppl. 1): I9–I16.
11. BissT. T., Brandão L.R., Kahr W.H. et al. Clinical features and outcome of pulmonary embolism in children. Br. J. Haematol. 2008; 142 (5): 808–818.
12. Andrew M., David M., Adams M. et al. Venous throm boembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood. 1994; 83 (5): 1251–1257.
13. Stein P.D., Kayali F., Olson R.E. Incidence of venous throm boembolism in infants and children: data from the National Hospital Discharge Survey. J. Pediatr. 2004; 145 (4): 563–565.
14. van Ommen C.H., Heijboer H., Büller H.R. et al. Venous thromboembolism in childhood: a prospective twoyear registry in The Netherlands. J. Pediatr. 2001; 139 (5):676–681.
15. Kearon C., Akl E.A. Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism. Blood. 2014; 123 (12): 1794–1801.
16. Rogers M.A., Levine D.A., Blumberg N. et al. Triggers of hospitalization for venous thromboembolism. Circulation. 2012; 125 (17): 2092–2099.
17. Ku G.H., White R.H., Chew H.K. et al. Venous throm boembolism in patients with acute leukemia: incidence, risk factors, and effect on survival. Blood. 2009; 113 (17):3911–3917.
18. Chew H.K., Wun T., Harvey D. et al. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch. Intern. Med. 2006; 166 (4):458–464.
19. Blom J.W., Doggen C.J., Osanto S., Rosendaal F.R. Malig nancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005; 293 (6): 715–722.
20. Timp J.F., Braekkan S.K., Versteeg H.H., Cannegieter S.C. Epidemiology of cancerassociated venous thrombosis. Blood. 2013; 122 (10): 1712–1723.
21. Gussoni G., Frasson S., La Regina M. et al. Threemonth mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry. Thromb. Res. 2013; 131 (1): 24–30.
22. BlancoMolina A., Rota L.L., Di Micco P. et al. Venous thromboembolism during pregnancy, postpartum or during contraceptive use. Thromb. Haemost. 2010; 103 (2):306–311.
23. BlancoMolina A., TrujilloSantos J., Tirado R. et al. Venous thromboembolism in women using hormonal contraceptives. Findings from the RIETE Registry. Thromb. Haemost. 2009; 101 (3): 478–482.
24. Pomp E.R., Lenselink A.M., Rosendaal F.R., Doggen C.J. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. Thromb. Haemost. 2008; 6 (4): 632–637.
25. Henriksson P., Westerlund E., Wallén H. et al. Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study. Br. Med. J. 2013; 346: e8632.
26. Sweetland S., Beral V., Balkwill A. et al. Venous throm boembolism risk in relation to use of different types of post menopausal hormone therapy in a large prospective study. Thromb. Haemost. 2012; 10 (11): 2277–2286.
27. Clayton T.C., Gaskin M., Meade T.W. Recent respiratory infection and risk of venous thromboembolism: casecon trol study through a general practice database. Int. J. Epidemiol. 2011; 40 (3): 819–827.
28. Smeeth L., Cook C., Thomas S. et al. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet. 2006; 367 (9516): 1075–1079.
29. Khorana A.A., Kuderer N.M., Culakova E. et al. Development and validation of a predictive model for chemotherapy associated thrombosis. Blood. 2008; 111 (10): 4902–4907.
30. Dijk F.N., Curtin J., Lord D., Fitzgerald D.A. Pulmonary embolismin children. Paediatr. Respir. Rev. 2012; 13 (2):112–122.
31. Piazza G., Goldhaber S.Z. Venous thromboembolism and atherothrombosis: an integrated approach. Circulation. 2010; 121 (19): 2146–2150.
32. Severinsen M.T., Kristensen S.R., Johnsen S.P. et al. Smoking and venous thromboembolism: a Danish follow up study. Thromb. Haemost. 2009; 7 (8): 1297–1303.
33. Steffen L.M., Cushman M., Peacock J.M. et al. Metabolic syndrome and risk of venous thromboembolism: Long itudinal Investigation of Thromboembolism Etiology. Thromb. Haemost. 2009; 7 (5): 746–751.
34. Ageno W., Becattini C., Brighton T. et al. Cardiovascular risk factors and venous thromboembolism: a metaanalysis. Circulation. 2008; 117 (1): 93–102.
35. Montecucco F., Mach F. Should we focus on «venous vulnerability» instead of «plaque vulnerability» in symptomatic atherosclerotic patients? Thromb. Haemost. 2011; 106 (6):995–996.
36. Piazza G., Goldhaber S.Z., Lessard D.M. et al. Venous thromboembolism in patients with symptomatic atheroscle rosis. Thromb. Haemost. 2011; 106 (6): 1095–1102.
37. Gresele P., Momi S., Migliacci R. Endothelium, venous thromboembolism and ischaemic cardiovascular events. Thromb. Haemost. 2010; 103 (1): 56–61.
38. Fox E.A., Kahn S.R. The relationship between inflamma tion and venous thrombosis. A systematic review of clinical studies. Thromb. Haemost. 2005; 94 (2): 362–365.
39. Enga K.F., Braekkan S.K., HansenKrone I.J. et al. Cigarette smoking and the risk of venous thromboem bolism: the Tromso Study. Thromb. Haemost. 2012; 10 (10):2068–2074.
40. Wattanakit K., Lutsey P.L., Bell E.J. et al. Association between cardiovascular disease risk factors and occurrence of venous thromboembolism. A timedependent analysis. Thromb. Haemost. 2012; 108 (3): 508–515.
41. Sørensen H.T., HorvathPuho E., Lash T.L. et al. Heart disease may be a risk factor for pulmonary embolism without peripheral deep venous thrombosis. Circulation. 2011; 124 (13): 1435–1441.
42. Prandoni P., Pesavento R., Sorensen H.T. et al. Prevalence of heart diseases in patients with pulmonary embolism with and without peripheral venous thrombosis: findings from a crosssectional survey. Eur. J. Intern. Med. 2009; 20 (5):470–473.
43. Sørensen H.T., HorvathPuho E., Pedersen L. et al. Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20year cohort study. Lancet. 2007; 370 (9601): 1773–1779.
44. Kakkar V.V., Howe C.T., Flanc C., Clarke M.B. Natural history of postoperative deepvein thrombosis. Lancet. 1969; 2 (7614): 230–232.
45. Dalen J.E. Pulmonary embolism: what have we learned since Virchow? Natural history, pathophysiology, and diagnosis. Chest. 2002; 122 (4): 1440–1456.
46. Kearon C. Natural history of venous thromboembolism. Circulation. 2003; 107 (23, Suppl. 1): I22–I30.
47. Aujesky D., Obrosky D.S., Stone R.A. et al. Aprediction rule to identify lowrisk patients with pulmonary embolism. Arch. Intern. Med. 2006; 166 (2): 169–175.
48. Laporte S., Mismetti P., Décousus H. et al. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation. 2008; 117 (13): 1711–1716.
49. Goldhaber S.Z., Visani L., De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Coope rative Pulmonary Embolism Registry (ICOPER). Lancet. 1999; 353 (9162): 1386–1389.
50. Miniati M., Monti S., Bottai M. et al. Survival and restora tion of pulmonary perfusion in a longterm followup of patients after acute pulmonary embolism. Medicine (Baltimore). 2006; 85 (5): 253–262.
51. Cosmi B., Nijkeuter M., Valentino M. et al. Residualemboli on lung perfusion scan or multidetector computed tomography after a first episode of acute pulmonary embolism. Intern. Emerg. Med. 2011; 6 (6): 521–528.
52. Sanchez O., Helley D., Couchon S. et al. Perfusion defects after pulmonary embolism: risk factors and clinical significance. Thromb. Haemost. 2010; 8 (6): 1248–1255.
53. Becattini C., Agnelli G., Pesavento R. et al. Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest. 2006; 130 (1): 172–175.
54. Pengo V., Lensing A.W., Prins M.H. et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N. Engl. J. Med. 2004; 350 (22): 2257–2264.
55. Kyrle P.A., Rosendaal F.R., Eichinger S. Risk assessment for recurrent venous thrombosis. Lancet. 2010; 376 (9757):2032–2039.
56. Zhu T., Martinez I., Emmerich J. Venous thromboem bolism: risk factors for recurrence. Arterioscler. Thromb. Vasc. Biol. 2009; 29 (3): 298–310.
57. Heit J.A. Predicting the risk of venous thromboembolism recurrence. Am. J. Hematol. 2012; 87 (Suppl. 1): S63–S67.
58. Heit J.A., Lahr B.D., Petterson T.M. et al. Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a populationbased cohort study. Blood. 2011; 118 (18):4992–4999.
59. Iorio A., Kearon C., Filippucci E. et al. Risk of recurrence after a first episode of symptomatic venous thromboem bolism provoked by a transient risk factor: a systematic review. Arch. Intern. Med. 2010; 170 (19): 1710–1716.
60. Douketis J., Tosetto A., Marcucci M. et al. Risk of recurrence after venous thromboembolism in men and women: patient level metaanalysis. Br. Med. J. 2011; 342: d813.
61. Lijfering W.M., Veeger N.J., Middeldorp S. et al. Alower risk of recurrent venous thrombosis inwomencompared with men is explained by sexspecific risk factors at time of first venous thrombosis in thrombophilic families. Blood. 2009; 114 (10): 2031–2036.
62. Cosmi B., Legnani C., Tosetto A. et al. Usefulness of repeated Ddimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study. Blood. 2010; 115 (3):481–488.
63. Rodger M.A., Kahn S.R., Wells PS. et al. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. Can. Med. Ass. J. 2008; 179 (5): 417–426.
64. Eichinger S., Minar E., Bialonczyk C. et al. Ddimer levels and risk of recurrent venous thromboembolism. JAMA. 2003; 290 (8): 1071–1074.
65. Coppens M., Reijnders J.H., Middeldorp S. et al. Testing for inherited thrombophilia does not reduce the recurrence of venous thrombosis. Thromb. Haemost. 2008; 6 (9):1474–1477.
66. Kearon C., Julian J.A., Kovacs M.J. et al. Influence of thrombophilia on risk of recurrent venous thromboem bolism while on warfarin: results from a randomized trial. Blood. 2008; 112 (12): 4432–4436.
67. McIntyre K.M., Sasahara A.A. The hemodynamic response to pulmonaryembolism in patients without prior cardiopul monary disease. Am. J. Cardiol. 1971; 28 (3): 288–294.
68. Smulders Y.M. Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction. Cardiovasc. Res. 2000; 48 (1): 23–33.
69. Delcroix M., Mélot C, Lejeune P. et al. Effects of vasodilators on gas exchange in acute canine embolic pulmonary hypertension. Anesthesiology. 1990; 72 (1): 77–84.
70. Huet Y., BrunBuisson C., Lemaire F. et al. Cardiopul monary effects of ketanserin infusion in human pulmonary embolism. Am. Rev. Respir. Dis. 1987; 135 (1): 114–117.
71. Lankhaar J.W., Westerhof N., Faes T.J. et al. Quantification of right ventricular afterload in patients with and without pulmonary hypertension. Am. J. Physiol. Heart Circ. Physiol. 2006; 291 (4): H1731–H1737.
72. Molloy W.D., Lee K.Y., Girling L. et al. Treatment of shock in a canine model of pulmonary embolism. Am. Rev. Respir. Dis. 1984; 130 (5): 870–874.
73. Marcus J.T., Gan C.T., Zwanenburg J.J. et al. Inter ventricular mechanical asynchrony in pulmonary arterial hypertension: lefttoright delay in peak shortening is related to right ventricular overload and left ventricular under filling. J. Am. Coll. Cardiol. 2008; 51 (7): 750–757.
74. Mauritz G.J., Marcus J.T., Westerhof N. et al. Prolonged right ventricular postsystolic isovolumic period in pulmonary arterial hypertension is not a reflection of diastolic dysfunction. Heart. 2011; 97 (6): 473–478.
75. Begieneman M.P., van de Goot F.R., van der Bilt I.A. et al. Pulmonary embolism causes endomyocarditis in the human heart. Heart. 2008; 94 (4): 450–456.
76. Hull R.D., Raskob G.E., Hirsh J. et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximalvein thrombosis. N. Engl. J. Med. 1986; 315 (18): 1109–1114.
77. Lankeit M., Jiménez D., Kostrubiec M. et al. Predictive value of the highsensitivity troponin T assay and the simplified pulmonary embolism severity index in hemodynamically stable patients with acute pulmonary embolism: a prospective validation study. Circulation. 2011; 124 (24): 2716–2724.
78. Lankeit M., Kempf T., Dellas C. et al. Growth differentia tion factor15 for prognostic assessment of patients with acute pulmonary embolism. Am. J. Respir. Crit. Care Med. 2008; 177 (9): 1018–1025.
79. Mehta N.J., Jani K., Khan I.A. Clinical usefulness and prognostic value of elevated cardiac troponin I levels in acute pulmonary embolism. Am. Heart J. 2003; 145 (5):821–825.
80. Burrowes K.S., Clark A.R., Tawhai M.H. Blood. flow redis tribution and ventilationperfusion mismatch during embolic pulmonary arterial occlusion. Pulm. Circ. 2011; 1 (3):365–376.
81. Konstantinides S., Geibel A., Kasper W. et al. Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism (see comments). Circulation. 1998; 97 (19): 1946–1951.
82. Miniati M., Prediletto R., Formichi B. et al. Accuracy of clinical assessment in the diagnosis of pulmonary embolism. Am. J. Respir. Crit. Care Med. 1999; 159 (3): 864–871.
83. Pollack C.V., Schreiber D., Goldhaber S.Z. et al. Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). J. Am. Coll. Cardiol. 2011; 57 (6): 700–706.
84. Wells P.S., Ginsberg J.S., Anderson D.R. et al. Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann. Intern. Med. 1998; 129 (12): 997–1005.
85. Thames M.D., Alpert J.S., Dalen J.E. Syncope in patients with pulmonary embolism. JAMA. 1977; 238 (23):2509–2511.
86. Stein P.D., Henry J.W. Clinical characteristics of patients with acute pulmonary embolism stratified according to their presenting syndromes. Chest. 1997; 112 (4): 974–979.
87. White R.H. The epidemiology of venous thromboem bolism. Circulation. 2003; 107 (23, Suppl. 1): I4–I8.
88. Rodger M.A., Carrier M., Jones G.N. et al. Diagnostic value of arterial blood. Gas measurement in suspected pulmonary embolism. Am. J. Respir. Crit. Care Med. 2000; 162(6): 2105–2108.
89. Stein P.D., Goldhaber S.Z., Henry J.W., Miller A.C. Arterial blood gas analysis in the assessment of suspected acute pulmonary embolism. Chest. 1996; 109 (1): 78–81.
90. Elliott C.G., Goldhaber S.Z., Visani L., DeRosa M. Chest. radiographs in acute pulmonary embolism. Results from the International Cooperative Pulmonary Embolism Registry. Chest. 2000; 118 (1): 33–38.
91. Geibel A., Zehender M., Kasper W. et al. Prognostic value of the ECG on admission in patients with acute major pulmonary embolism. Eur. Respir. J. 2005; 25 (5): 843–848.
92. Miniati M., Pistolesi M., Marini C. et al. Value of perfusion lung scan in the diagnosis of pulmonary embolism: results of the Prospective Investigative Study of Acute Pulmonary Embolism Diagnosis (PISAPED). Am. J. Respir. Crit. Care Med. 1996; 154 (5): 1387–1393.
93. Musset D., Parent F., Meyer G. et al. Diagnostic strategy for patients with suspected pulmonary embolism: a prospective multicentre outcome study. Lancet. 2002; 360 (9349):1914–1920.
94. Le Gal G., Righini M., Roy P.M. et al. Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann. Intern. Med. 2006; 144 (3): 165–171.
95. PIOPED Investigators. Value of the ventilation / perfusion scan in acute pulmonary embolism. Results of the prospec tive investigation of pulmonary embolismdiagnosis (PIOPED). JAMA. 1990; 263 (20): 2753–2759.
96. Wells P.S., Anderson D.R., Rodger M. et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED Ddimer. Thromb. Haemost. 2000; 83 (3):416–420.
97. Anderson D.R., Kovacs M.J., Dennie C. et al. Use of spiral computed tomography contrast angiography and ultra sonography to exclude the diagnosis of pulmonary embolism in the emergency department. J. Emerg. Med. 2005; 29 (4): 399–404.
98. Kearon C., Ginsberg J.S., Douketis J. et al. An evaluation of Ddimer in the diagnosis of pulmonary embolism: a randomized trial. Ann. Intern. Med. 2006; 144 (11): 812–821.
99. Söhne M., Kamphuisen P.W., van Mierlo P.J., Büller H.R. Diagnostic strategy using a modified clinical decision rule and Ddimer test to rule out pulmonary embolism in elderly in and outpatients. Thromb. Haemost. 2005; 94 (1):206–210.
100. van Belle A., Büller H.R., Huisman M.V. et al. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, Ddimer testing, and computed tomography. JAMA. 2006; 295 (2): 172–179.
101. Wells P.S., Anderson D.R., Rodger M. et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and Ddimer. Ann. Intern. Med. 2001; 135 (2): 98–107.
102. Rodger M.A., Maser E., Stiell I. et al. The interobserver reliability of pretest probability assessment in patients with suspected pulmonary embolism. Thromb. Res. 2005; 116 (2): 101–107.
103. Runyon M.S., Webb W.B., Jones A.E., Kline J.A. Comparison of the unstructured clinician estimate of pretest probability for pulmonary embolism to the Canadian score and the Charlotte rule: a prospective observational study. Acad. Emerg. Med. 2005; 12 (7): 587–593.
104. Wolf S.J., McCubbin T.R., Feldhaus K.M. et al. Prospective validation of Wells Criteria in the evaluation of patients with suspected pulmonary embolism. Ann. Emerg. Med. 2004; 44 (5): 503–510.
105. Ceriani E., Combescure C., Le Gal G. et al. Clinical prediction rules for pulmonary embolism: a systematic review and metaanalysis. Thromb. Haemost. 2010; 8 (5):957–970.
106. Douma R.A., MosI C., Erkens P.M. et al. Performance of 4 clinical decision rules in the diagnostic management of acute pulmonary embolism: a prospective cohort study. Ann. Intern. Med. 2011; 154 (11): 709–718.
107. Lucassen W., Geersing G.J., Erkens P.M. et al. Clinical decision rules for excluding pulmonary embolism: a meta analysis. Ann. Intern. Med. 2011; 155 (7): 448–460.
108. Gibson N.S., Sohne M., Kruip M.J. et al. Further validation and simplification of the Wells clinical decision rule in pulmonary embolism. Thromb. Haemost. 2008; 99 (1): 229–234.
109. Klok F.A., Mos I.C., Nijkeuter M. et al. Simplification of the revised Geneva score for assessing clinical probability of pulmonary embolism. Arch. Intern. Med. 2008; 168 (19): 2131–2136.
110. Douma R.A., Gibson N.S., Gerdes V.E. et al. Validity and clinical utility of the simplified Wells rule for assessing clinical probability for the exclusion of pulmonary embolism. Thromb. Haemost. 2009; 101 (1): 197–200.
111. Di Nisio M., Squizzato A., Rutjes A.W. et al. Diagnostic accuracy of Ddimer test for exclusion of venous throm boembolism: a systematic review. Thromb. Haemost. 2007; 5 (2): 296–304.
112. Stein P.D., Hull R.D., Patel K.C. etal. Ddimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann. Intern. Med. 2004; 140 (8): 589–602.
113. Perrier A., Roy P.M., Aujesky D. et al. Diagnosing pulmonary embolism in outpatients with clinical assessment, Ddimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study. Am. J. Med. 2004; 116 (5): 291–299.
114. Perrier A., Roy P.M., Sanchez O. et al. Multidetectorrow computed tomography in suspected pulmonary embolism. N. Engl. J. Med. 2005; 352 (17): 1760–1768.
115. Perrier A., Desmarais S., Miron M.J. et al. Noninvasive diagnosis of venous thromboembolism in outpatients. Lancet. 1999; 353 (9148): 190–195.
116. Kruip M.J., Slob M.J., Schijen J.H. et al. Use of a clinical decision rule in combination with Ddimer concentration in diagnostic workup of patients with suspected pulmonary embolism: a prospective management study. Arch. Intern. Med. 2002; 162 (14): 1631–1635.
117. Righini M., Le Gal G., Aujesky D. et al. Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised noninferiority trial. Lancet. 2008; 371 (9621): 1343–1352.
118. Carrier M., Righini M., Djurabi R.K. et al. VIDAS Ddimer in combination with clinical pretest probability to rule out pulmonary embolism. A systematic review of management outcome studies. Thromb. Haemost. 2009; 101 (5):886–892.
119. Geersing G.J., Erkens P.M., Lucassen W.A. et al. Safe exclusion of pulmonary embolism using the Wells rule and qualitative Ddimer testing in primary care: prospective cohort study. Br. Med. J. 2012; 345: e6564.
120. Righini M., Goehring C., Bounameaux H., Perrier A. Effects of age on the performance of common diagnostic tests for pulmonary embolism. Am. J. Med. 2000; 109 (5): 357–361.
121. Douma R.A., Le G.G., Sohne M. et al. Potential of an age adjusted Ddimer cutoff value to improve the exclusion of pulmonary embolism in older patients: a retrospective analy sis of three large cohorts. Br. Med. J. 2010; 340: c1475.
122. Penaloza A., Roy P.M., Kline J. et al. Performance of age adjusted Ddimer cutoff to rule out pulmonary embolism. Thromb. Haemost. 2012; 10 (7): 1291–1296.
123. Schouten H.J., Geersing G.J., Koek H.L. et al. Diagnostic accuracy of conventional or age adjusted Ddimer cutoff values in older patients with suspected venous thromboem bolism: systematic review and metaanalysis. Br. Med. J. 2013; 346: f2492.
124. Righini M., Van Es J., den Exter P.L. et al. Ageadjusted D dimer cutoff levels to rule out pulmonary embolism: the ADJUSTPE study. JAMA. 2014; 311 (11): 1117–1124.
125. Di Nisio M., Söhne M., Kamphuisen P.W., Büller H.R. D Dimer test in cancer patients with suspected acute pulmonary embolism. Thromb. Haemost. 2005; 3 (6):1239–1242.
126. Righini M., Le Gal G., De Lucia S. et al. Clinical usefulness of Ddimer testing in cancer patients with suspected pulmonary embolism. Thromb. Haemost. 2006; 95 (4):715–719.
127. Miron M.J., Perrier A., Bounameaux H. et al. Contribution of noninvasive evaluation to the diagnosis of pulmonary embolism in hospitalized patients. Eur. Respir. J. 1999; 13 (6): 1365–1370.
128. Chabloz P., Reber G., Boehlen F. et al. TAFI antigen and Ddimer levels during normal pregnancy and at delivery. Br. J. Haematol. 2001; 115 (1): 150–152.
129. Francalanci I., Comeglio P., Liotta A.A. et al. Ddimer concentrations during normal pregnancy, as measured by ELISA. Thromb. Res. 1995; 78 (5): 399–405.
130. Leclercq M.G., Lutisan J.G., van Marwijk Kooy M. et al. Ruling out clinically suspected pulmonary embolism by assessment of clinical probability and Ddimer levels: a management study. Thromb. Haemost. 2003; 89 (1): 97–103.
131. Ten Wolde M., Hagen P.J., Macgillavry M.R. et al. Non invasive diagnostic workup of patients with clinically suspected pulmonary embolism; results of a management study. Thromb. Haemost. 2004; 2 (7): 1110–1117.
132. Ghaye B., Szapiro D., Mastora I. et al. Peripheral pulmonary arteries: how far in the lung does multidetector row spiral CT allow analysis? Radiology. 2001; 219 (3): 629–636.
133. Patel S., Kazerooni E.A., Cascade P.N. Pulmonary embolism: optimization of small pulmonary artery visualization at multidetector row CT. Radiology. 2003; 227 (2): 455–460.
134. RemyJardin M., Remy J., Wattinne L., Giraud F. Central pulmonary thromboembolism: diagnosis with spiral volumetric CT with the singlebreathhold technique: comparison with pulmonary angiography. Radiology. 1992; 185 (2): 381–387.
135. Stein P.D., Fowler S.E., Goodman L.R. et al. Multidetector computed tomography for acute pulmonary embolism. N. Engl. J. Med. 2006; 354 (22): 2317–2327.
136. Anderson D.R., Kahn S.R., Rodger M.A. et al. Computed tomographic pulmonary angiography vs ventilationperfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial. JAMA. 2007; 298 (23): 2743–2753.
137. Carrier M., Righini M., Wells P.S. et al. Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and metaanalysis of the management outcome studies. Thromb. Haemost. 2010; 8 (8): 1716–1722.
138. Stein P.D., Goodman L.R., Hull R.D. et al. Diagnosis and management of isolated subsegmental pulmonary embolism: reviewand assessment of the options. Clin. Appl. Thromb Hemost. 2012; 18 (1): 20–26.
139. Goodman L.R., Stein P.D., Matta F. et al. CT venography and compression sonography are diagnostically equivalent: data from PIOPED II. Am. J. Roentgenol. 2007; 189 (5): 1071–1076.
140. Brenner D.J., Hall E.J. Computed tomography: an increasing source of radiation exposure. N. Engl. J. Med. 2007; 357 (22): 2277–2284.
141. Farrell C., Jones M., Girvin F. et al. Unsuspected pulmonary embolism identified using multidetector computed tomography in hospital outpatients. Clin. Radiol. 2010; 65 (1): 1–5.
142. Jia C.F., Li Y.X., Yang Z.Q. et al. Prospective evaluation of unsuspected pulmonary embolism on coronary computed tomographic angiography. J. Comput. Assist. Tomogr. 2012; 36 (2): 187–190.
143. Palla A., Rossi G., Falaschi F. et al. Is incidentally detected pulmonary embolism in cancer patients less severe? A case control study. Cancer Invest. 2012; 30 (2): 131–134.
144. Sahut D’Izarn M., Caumont Prim A., Planquette B. et al. Risk factors and clinical outcome of unsuspected pulMonary embolism in cancer patients: a casecontrol study. Thromb. Haemost. 2012; 10 (10): 2032–2038.
145. Kearon C., Akl E.A., Comerota A.J. et al. Antithrombotic therapy for VTE disease: Antithrombotic therapy and prevention of thrombosis, 9th ed.: American College of Chest. Physicians EvidenceBased Clinical Practice Guidelines. Chest. 2012; 141 (2, Suppl.): e419S–e494S.
146. Alderson P.O. Scintigraphic evaluation of pulmonary embolism. Eur. J. Nucl. Med. 1987; 13 (Suppl.): S6–10.
147. Miller R.F., O'Doherty M.J. Pulmonary nuclear medicine. Eur. J. Nucl. Med. 1992; 19 (5): 355–368.
148. Roach P.J., Schembri G.P., Bailey D.L. V/Q scanning using SPECT and SPECT / CT. J. Nucl. Med. 2013; 54 (9): 1588–1596.
149. Schembri G.P., Miller A.E., Smart R. Radiation dosimetry and safety issues in the investigation of pulmonary embolism. Semin. Nucl. Med. 2010; 40 (6): 442–454.
150. Reid J.H., Coche E.E., Inoue T. et al. Is the lung scan alive and well? Facts and controversies in defining the role of lung scintigraphy for the diagnosis of pulmonary embolism in the era of MDCT. Eur. J. Nucl. Med. Mol. Imaging. 2009; 36 (3): 505–521.
151. Gottschalk A., Sostman H.D., Coleman R.E. et al. Ventilationperfusion scintigraphy in the PIOPED study. Part II. Evaluation of the scintigraphic criteria and interpre tations. J. Nucl. Med. 1993; 34 (7): 1119–1126.
152. Sostman H.D., Coleman R.E., DeLong D.M. et al. Evaluation of revised criteria for ventilationperfusion scintigraphy in patients with suspected pulmonary emboLism. Radiology. 1994; 193 (1): 103–107.
153. Bajc M., Olsson B., Palmer J., Jonson B. Ventilation / Perfusion SPECT for diagnostics of pulmonary embolism in clinical practice. J. Intern. Med. 2008; 264 (4): 379–387.
154. Glaser J.E., Chamarthy M., Haramati L.B. et al. Successful and safe implementation of a trinary interpretation and reporting strategy for V/Q lung scintigraphy. J. Nucl. Med. 2011; 52 (10): 1508–1512.
155. Sostman H.D., Stein P.D., Gottschalk A. et al. Acute pulmonary embolism: sensitivity and specificity of ventilation perfusion scintigraphy in PIOPED II study. Radiology. 2008; 246 (3): 941–946.
156. Stein P.D., Terrin M.L., Gottschalk A. et al. Value of ventilation / perfusion scans vs. perfusion scans alone in acute pulmonary embolism. Am. J. Cardiol. 1992; 69 (14):1239–1241.
157. Miniati M., Monti S., Bauleo C. et al. A diagnostic strategy for pulmonary embolism based on standardised pretest probability and perfusion lung scanning: a management study. Eur. J. Nucl. Med. Mol. Imaging. 2003; 30 (11):1450–1456.
158. Roy P.M., Colombet I., Durieux P. et al. Systematic review and metaanalysis of strategies for the diagnosis of suspected pulmonary embolism. Br. Med. J. 2005; 331 (7511): 259.
159. Collart J.P., Roelants V., Vanpee D. et al. Is a lung perfusion scan obtained by using single photon emission computed tomography able to improve the radionuclide diagnosis of pulmonary embolism? Nucl. Med. Commun. 2002; 23 (11): 1107–1113.
160. Corbus H.F., Seitz J.P., Larson R.K. et al. Diagnostic use fulness of lung SPET in pulmonary thromboembolism: an outcome study. Nucl. Med. Commun. 1997; 18 (10): 897–906.
161. Reinartz P., Wildberger J.E., Schaefer W. et al. Tomographic imaging in the diagnosis of pulmonary embolism: a comparison between V/Q lung scintigraphy in SPECT technique and multislice spiral CT. J. Nucl. Med. 2004; 45 (9):1501–1508.
162. Gutte H., Mortensen J., Jensen C.V. et al. Detection of pulmonary embolism with combined ventilationperfusion SPECT and lowdose CT: headtohead comparison with multidetector CT angiography. J. Nucl. Med. 2009; 50 (12): 1987–1992.
163. Reinartz P., Kaiser H.J., Wildberger J.E. et al. SPECT imaging in the diagnosis of pulmonary embolism: automat ed detection of match and mismatch defects by means of imageprocessing techniques. J. Nucl. Med. 2006; 47 (6): 968–973.
164. van Beek E.J., Reekers J.A., Batchelor D.A. et al. Feasi bility, safety and clinical utility of angiography in patients with suspected pulmonary embolism. Eur. Radiol. 1996; 6 (4): 415–419.
165. Diffin D.C., Leyendecker J.R., Johnson S.P. et al. Effect of anatomic distribution of pulmonary emboli on interobserv er agreement in the interpretation of pulmonary angiography. Am. J. Roentgenol. 1998; 171 (4): 1085–1089.
166. Stein P.D., Henry J.W., Gottschalk A. Reassessment of pulmonary angiography for the diagnosis of pulmonary embolism: relation of interpreteragreement to the order of the involved pulmonary arterial branch. Radiology. 1999; 210 (3): 689–691.
167. Miller G.A., Sutton G.C., Kerr I.H. et al. Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism. Br. Heart J. 1971; 33 (4): 616.
168. Stein P.D., Athanasoulis C., Alavi A. et al. Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation. 1992; 85 (2): 462–468.
169. Wan S., Quinlan D.J., Agnelli G., Eikelboom J.W. Throm bolysiscompared with heparin for the initial treatment of pulmonary embolism: a metaanalysis of the randomized controlled trials. Circulation. 2004; 110 (6): 744–749.
170. Engelberger R.P., Kucher N. Catheterbased reperfusion treatment of pulmonary embolism. Circulation. 2011; 124 (19): 2139–2144.
171. Revel M.P., Sanchez O., Couchon S. et al. Diagnostic accuracy of magnetic resonance imaging for an acute pulmonary embolism: results of the IRMEP study. Thromb. Haemost. 2012; 10 (5): 743–750.
172. Stein P.D., Chenevert T.L., Fowler S.E. et al. Gadolinium enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann. Intern. Med. 2010; 152 (7): 434–3.
173. Grifoni S., Olivotto I., Cecchini P. et al. Shortterm clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation. 2000; 101 (24): 2817– 2822.
174. Torbicki A., Kurzyna M., Ciurzynski M. et al. Proximal pulmonary emboli modify right ventricular ejection pattern. Eur. Respir. J. 1999; 13 (3): 616–621.
175. Bova C., Greco F., Misuraca G. et al. Diagnostic utility of echocardiography in patients with suspected pulmonary embolism. Am. J. Emerg. Med. 2003; 21 (3): 180–183.
176. Kurzyna M., Torbicki A., Pruszczyk P. et al. Disturbed right ventricular ejection pattern as a new Doppler echocardio graphic sign of acute pulmonary embolism. Am. J. Cardiol. 2002; 90 (5): 507–511.
177. Casazza F., Bongarzoni A., Capozi A., Agostoni O. Regional right ventricular dysfunction in acute pulmonary embolism and right ventricular infarction. Eur. J. Echo' cardiogr. 2005; 6 (1): 11–14.
178. Pruszczyk P., Goliszek S., Lichodziejewska B. et al. Prognostic value of echocardiography in normotensive patients with acute pulmonary embolism. JACC Cardiovasc. Imaging. 2014; 7 (6): 553–560.
179. Rudski L.G., Lai W.W., Afilalo J. et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardio graphy, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J. Am. Soc. Echocardiogr. 2010; 23 (7): 685–713.
180. Platz E., Hassanein A.H., Shah A. et al. Regional right ventricular strain pattern in patients with acute pulmonary embolism. Echocardiography. 2012; 29 (4): 464–470.
181. Sugiura E., Dohi K., Onishi K. et al. Reversible right ventricular regional nonuniformity quantified by speckle tracking strain imaging in patients with acute pulmonary thromboembolism. J. Am. Soc. Echocardiogr. 2009; 22 (12):1353–1359.
182. Hsiao S.H., Chang S.M., Lee C.Y. et al. Usefulness of tissue Doppler parameters for identifying pulmonary embolism in patients with signs of pulmonary hypertension. Am. J. Cardiol. 2006; 98 (5): 685–690.
183. Kucher N., Luder C.M., Dörnhöfer T. et al. Novel management strategy for patients with suspected pulmonary embolism. Eur. Heart J. 2003; 24 (4): 366–376.
184. Mansencal N., Attias D., Caille V. et al. Computed tomography for the detection of freefloating thrombi in the right heart in acute pulmonary embolism. Eur. Radiol. 2011; 21 (2): 240–245.
185. Torbicki A., Galiè N., Covezzoli A. et al. Right heart thrombi in pulmonary embolism: results from the International Cooperative Pulmonary Embolism Registry. J. Am. Coll. Cardiol. 2003; 41 (12): 2245–2251.
186. Casazza F., Bongarzoni A., Centonze F., Morpurgo M. Prevalence and prognostic significance of rightsided cardiac mobile thrombi in acute massive pulmonary embolism. Am. J. Cardiol. 1997; 79 (10): 1433–1435.
187. Mollazadeh R., Ostovan M.A., Abdi Ardekani A.R. Right cardiac thrombus in transit among patients with pulmonary thromboemboli. Clin. Cardiol. 2009; 32 (6): E27–E31.
188. Rose P.S., Punjabi N.M., Pearse D.B. Treatment of right heart thromboemboli. Chest. 2002; 121 (3): 806–814.
189. Krivec B., Voga G., Zuran I. et al. Diagnosis and treatment of shock due to massive pulmonary embolism: approach with transesophageal echocardiography and intrapul monary thrombolysis. Chest. 1997; 112 (5): 1310–1316.
190. Pruszczyk P., Torbicki A., KuchWocial A. et al. Diagnostic value of transoesophageal echocardiography in suspected haemodynamically significant pulmonary embolism. Heart. 2001; 85 (6): 628–634.
191. Pruszczyk P., Torbicki A., Pacho R. et al. Noninvasive diagnosis of suspected severe pulmonary embolism: transesophageal echocardiography vs. spiral CT. Chest. 1997; 112 (3): 722–728.
192. Hull R.D., Hirsh J., Carter C.J. et al. Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann. Intern. Med. 1983; 98 (6): 891–899.
193. Kearon C., Ginsberg J.S., Hirsh J. The role of venous ultra sonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism. Ann. Intern. Med. 1998; 129 (12): 1044–1049.
194. Perrier A., Bounameaux H. Ultrasonography of leg veins in patients suspected of having pulmonary embolism. Ann. Intern. Med. 1998; 128 (3): 243–245.
195. Le Gal G., Righini M., Sanchez O. et al. Apositive compression ultrasonography of the lower limb veins is highly predictive of pulmonary embolism on computed tomography in suspected patients. Thromb. Haemost. 2006; 95 (6): 963–966.
196. Elias A., Colombier D., Victor G. et al. Diagnostic performance of complete lower limb venous ultrasound in patients with clinically suspected acute pulmonary embolism. Thromb. Haemost. 2004; 91 (1): 187–195.
197. Righini M., Le G.G., Aujesky D. et al. Complete venous ultrasound in outpatients with suspected pulmonary embolism. Thromb. Haemost. 2009; 7 (3): 406–412.
198. Kline J.A., Webb W.B., Jones A.E., HernandezNino J. Impact of a rapid ruleout protocol for pulmonary embolism on the rate of screening, missed cases, and pulmonary vascular imaging in an urban US emergency department. Ann. Emerg. Med. 2004; 44 (5): 490–502.
199. Roy P.M., Meyer G., Vielle B. et al. Appropriateness of diagnostic management and outcomes of suspected pulmonary embolism. Ann. Intern. Med. 2006; 144 (3): 157–164.
200. Ferrari E., Benhamou M., Berthier F., Baudouy M. Mobile thrombi of the right heart in pulmonary embolism: delayed disappearance after thrombolytic treatment. Chest. 2005;127 (3): 1051–1053.
201. PierreJustin G., Pierard L.A. Management of mobile right heart thrombi: a prospective series. Int. J. Cardiol. 2005; 99 (3): 381–388.
202. VieillardBaron A., Qanadli S.D., Antakly Y. et al. Transesophageal echocardiography for the diagnosis of pulmonary embolism with acute cor pulmonale: a comparison with radiological procedures. Intensive Care Med. 1998; 24 (5): 429–433.
203. Righini M., Aujesky D., Roy P.M. et al. Clinical usefulness of Ddimer depending on clinical probability and cutoffvalue in outpatients with suspected pulmonary embolism. Arch. Intern. Med. 2004; 164 (22): 2483–2487.
204. Perrier A., Miron M.J., Desmarais S. et al. Using clinical evaluation and lung scan to rule out suspected pulmonary embolism: Is it a valid option in patients with normal results of lowerlimb venous compression ultrasonography? Arch. Intern. Med. 2000; 160 (4): 512–516.
205. Stein P.D., Sostman H.D., Dalen J.E. et al. Controversies in diagnosis of pulmonary embolism. Clin. Appl. Thromb. Hemost. 2011; 17 (2): 140–149.
206. den Exter P.L., Van Es J., Klok F.A. et al. Risk profile and clinical outcome of symptomatic subsegmental acute pulmonary embolism. Blood. 2013; 122 (7): 1144–1149.
207. Wiener R.S., Schwartz L.M., Woloshin S. Whena test is too good: how CT pulmonary angiograms find pulmonary emboli that do not need to be found. Br. Med. J. 2013; 347: f3368.
208. Tsai J., Grosse S.D., Grant A.M. et al. Trends in inhospital deaths among hospitalizations with pulmonary embolism. Arch. Intern. Med. 2012; 172 (12): 960–961.
209. Wiener R.S., Schwartz L.M., Woloshin S. Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch. Intern. Med. 2011; 171 (9): 831–837.
210. Ayaram D., Bellolio M.F., Murad M.H. et al. Triple rule out computed tomographic angiography for chest pain: a diagnostic systematic review and metaanalysis. Acad. Emerg. Med. 2013; 20 (9): 861–871.
211. Jiménez D., Aujesky D., Díaz G. et al. Prognostic significance of deep vein thrombosis in patients presenting with acute symptomatic pulmonary embolism. Am. J. Respir. Crit. Care Med. 2010; 181 (9): 983–991.
212. Chan C.M., Woods C., Shorr A.F. The validation and reproducibility of the pulmonary embolism severity index. Thromb. Haemost. 2010; 8 (7): 1509–1514.
213. Donzé J., Le Gal G., Fine M.J. et al. Prospective validation of the Pulmonary Embolism Severity Index. A clinical prognostic model for pulmonary embolism. Thromb. Haemost. 2008; 100 (5): 943–948.
214. Vanni S., Nazerian P., Pepe G. et al. Comparison of two prognostic models for acute pulmonary embolism: clinical vs right ventricular dysfunctionguided approach. Thromb. Haemost. 2011; 9 (10): 1916–1923.
215. Aujesky D., Obrosky D.S., Stone R.A. et al. Derivation and validation of a prognostic model for pulmonary embolism. Am. J. Respir. Crit. Care Med. 2005; 172 (8): 1041–1046.
216. Jiménez D., Yusen R.D., Otero R. et al. Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy. Chest. 2007; 132 (1): 24–30.
217. Wicki J., Perrier A., Perneger T.V. et al. Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb. Haemost. 2000; 84 (4): 548–552.
218. Aujesky D., Roy P.M., Verschuren F. et al. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, openlabel, randomised, non inferiority trial. Lancet. 2011; 378 (9785): 41–48.
219. Jiménez D., Aujesky D., Moores L. et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch. Intern. Med. 2010; 170 (15): 1383–1389.
220. Righini M., Roy P.M., Meyer G. et al. The Simplified Pulmonary Embolism Severity Index (PESI): validation of a clinical prognostic model for pulmonary embolism. Thromb. Haemost. 2011; 9 (10): 2115–2117.
221. Sam A., Sánchez D., Gómez V. et al. The shock index and the simplified PESI for identification of lowrisk patients with acute pulmonary embolism. Eur. Respir. J. 2011; 37 (4): 762–766.
222. Lankeit M., Gomez V., Wagner C. et al. A strategy combining imaging and laboratory biomarkers in comparison with a simplified clinical score for risk stratification of patients with acute pulmonary embolism. Chest. 2012; 141 (4): 916–922.
223. Spirk D., Aujesky D., Husmann M. et al. Cardiac troponin testing and the simplified Pulmonary Embolism Severity Index. The SWIss Venous Thromboembolism Registry (SWIVTER). Thromb. Haemost. 2011; 106 (5): 978–984.
224. Kreit J.W. The impact of right ventricular dysfunction on the prognosis and therapy of normotensive patients with pulmonary embolism. Chest. 2004; 125 (4): 1539–1545.
225. Kucher N., Rossi E., De Rosa M., Goldhaber S.Z. Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher. Arch. Intern. Med. 2005; 165 (15): 1777–1781.
226. ten Wolde M., Söhne M., Quak E. et al. Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism. Arch. Intern. Med. 2004; 164 (15): 1685–1689.
227. Coutance G., Cauderlier E., Ehtisham J. et al. The prognostic value of markers of right ventricular dysfunction in pulmonary embolism: a metaanalysis. Crit. Care. 2011; 15 (2): R103.
228. Sanchez O., Trinquart L., Colombet I. et al. Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systemat ic review. Eur. Heart J. 2008; 29 (12): 1569–1577.
229. Becattini C., Agnelli G., Vedovati M.C. et al. Multidetector computed tomography for acute pulmonary embolism: diagnosis and risk stratification in a single test. Eur. Heart J. 2011; 32 (13): 1657–1663.
230. TrujilloSantos J., den Exter P.L., Gómez V. et al. Computed tomographyassessed right ventricular dysfunction and risk stratification of patients with acute nonmassive pulmonary embolism: systematic review and metaanalysis. Thromb. Haemost. 2013; 11 (10): 1823–1832.
231. Becattini C., Agnelli G., Germini F., Vedovati M.C. Computed tomography to assess risk of death in acute pulmonary embolism: a metaanalysis. Eur. Respir. J. 2014; 43 (6): 1678–1690.
232. Henzler T., Roeger S., Meyer M. et al. Pulmonary embolism: CT signs and cardiac biomarkers for predicting right ventricular dysfunction. Eur. Respir. J. 2012; 39 (4): 919–926.
233. Klok F.A., Mos I.C., Huisman M.V. Braintype natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and metaanalysis. Am. J. Respir. Crit. Care Med. 2008; 178 (4): 425–430.
234. Kucher N., Goldhaber S.Z. Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism. Circulation. 2003; 108 (18): 2191–2194.
235. Lankeit M., Jimenez D., Kostrubiec M. et al. Validation of Nterminal probrain natriuretic peptide cutoff values for risk stratification of pulmonary embolism. Eur. Respir. J. 2014; 43 (6): 1669–1677.
236. Vuilleumier N., Le Gal G., Verschuren F. et al. Cardiac biomarkers for risk stratification in nonmassive pulmonary embolism: a multicenter prospective study. Thromb. Haemost. 2009; 7 (3): 391–398.
237. Kostrubiec M., Pruszczyk P., Bochowicz A. et al. Biomarkerbased risk assessment model in acute pulmonary embolism. Eur. Heart J. 2005; 26 (20): 2166–2172.
238. Agterof M.J., Schutgens R.E., Snijder R.J. et al. Out of hospital treatment of acute pulmonary embolism in patients with a low NTproBNP level. Thromb. Haemost. 2010; 8 (6): 1235–1241.
239. ComaCanella I., Gamallo C., Martinez Onsurbe P., LopezSendon J. Acute right ventricular infarction secondary to massive pulmonary embolism. Eur. Heart J. 1988; 9 (5): 534–540.
240. Becattini C., Vedovati M.C., Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a metaanalysis. Circulation. 2007; 116 (4): 427–433.
241. Jiménez D., Uresandi F., Otero R. et al. Troponinbased risk stratification of patients with acute nonmassive pulmonary embolism: systematic review and metaanalysis. Chest. 2009; 136 (4): 974–982.
242. Lankeit M., Friesen D., Aschoff J. et al. Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolism. Eur. Heart J. 2010; 31 (15): 1836–1844.
243. Boscheri A., Wunderlich C., Langer M. et al. Correlation of hearttype fatty acidbinding protein with mortality and echocardiographic data in patients with pulmonary embolism at intermediate risk. Am. Heart J. 2010; 160 (2):294–300.
244. Puls M., Dellas C., Lankeit M. et al. Hearttype fatty acidbinding protein permits early risk stratification of pulmonary embolism. Eur. Heart J. 2007; 28 (2): 224–229.
245. Dellas C., Puls M., Lankeit M. et al. Elevated hearttype fatty acidbinding protein levels on admission predict an adverse outcome in normotensive patients with acute pulmonary embolism. J. Am. Coll. Cardiol. 2010; 55 (19): 2150–2157.
246. Lankeit M., Friesen D., Schafer K. et al. A simple score for rapid risk assessment of nonhighrisk pulmonary embolism. Clin. Res. Cardiol. 2013; 102 (1): 73–80.
247. Dellas C., Tschepe M., Seeber V. et al. A novel HFABP assay and a fast prognostic score for risk assessment of nor motensive pulmonary embolism. Thromb. Haemost. 2014; 111 (5).
248. Kostrubiec M., Labyk A., PedowskaWłoszek J. et al. Assessment of renal dysfunction improves troponinbased shortterm prognosis in patients with acute symptomatic pulmonary embolism. Thromb. Haemost. 2010; 8 (4): 651–658.
249. Kostrubiec M., Labyk A., PedowskaWłoszek J. et al. Neutrophil gelatinaseassociated lipocalin, cystatin C and eGFR indicate acute kidney injury and predict prognosis of patients with acute pulmonary embolism. Heart. 2012; 98 (16): 1221–1228.
250. Becattini C., Lignani A., Masotti L. et al. Ddimer for risk stratification in patients with acute pulmonary embolism. Thromb. Thrombolysis. 2012; 33 (1): 48–57.
251. Lobo J.L., Zorrilla V., Aizpuru F. et al. Ddimer levels and 15day outcome in acute pulmonaryembolism. Findings from the RIETE Registry. Thromb. Haemost. 2009; 7 (11): 1795–1801.
252. Aujesky D., Roy P.M., Guy M. et al. Prognostic value of Ddimer in patients with pulmonary embolism. Thromb. Haemost. 2006; 96 (4): 478–482.
253. Konstantinides S., Geibel A., Heusel G. et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N. Engl. J. Med. 2002; 347 (15): 1143–1150.
254. Meyer G., Vicaut E., DanaysT. et al. Fibrinolysis for patients with intermediaterisk pulmonary embolism. N. Engl. J. Med. 2014; 370 (15): 1402–1411.
255. Jiménez D., Aujesky D., Moores LG. et al. Combinations of prognostic tools for identification of highrisk normoten sive patients with acute symptomatic pulmonary embolism. Thorax. 2011; 66 (1): 75–81.
256. Agterof M.J., Schutgens R.E., Moumli N. et al. A prognostic model for short term adverse events in normotensive patients with pulmonary embolism. Am. J. Hematol. 2011; 86 (8): 646–649.
257. Becattini C., Casazza F., Forgione C. et al. Acute pulmonary embolism: external validation of an integrated risk stratification model. Chest. 2013; 144 (5): 1539–1545.
258. Sanchez O., Trinquart L., Caille V. et al. Prognostic factors for pulmonary embolism: the prep study, a prospective multicenter cohort study. Am. J. Respir. Crit. Care Med. 2010; 181 (2): 168–173.
259. Jiménez D., Kopecna D., Tapson V. et al. Derivation and validation of multimarker prognostication for normotensive patients with acute symptomatic pulmonary embolism. Am.J. Respir. Crit. Care Med. 2014; 189 (6): 718–726.
260. Bova C., Sanchez O., Prandoni P. et al. Identification of intermediaterisk patients with acute symptomatic pulmonary embolism. Eur. Respir. J. 2014.
261. Binder L., Pieske B., Olschewski M. et al. Nterminal probrain natriuretic peptide or troponin testing followed byechocardiography for risk stratification of acute pulmonaryembolism. Circulation. 2005; 112 (11): 1573–1579.
262. The PEITHO Steering Committee. Singlebolus tenecte plase plus heparin compared with heparin alone for nor motensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury: rationale and design of the Pulmonary Embolism Thrombolysis (PEITHO) trial. Am. Heart J. 2012; 163 (1): 33–38.
263. Sanchez O., Trinquart L., Planquette B. et al. Echo cardiography and pulmonary embolism severity index have independent prognostic roles in pulmonary embolism. Eur. Respir. J. 2013; 42 (3): 681–688.
Рецензия
Для цитирования:
статья Р. Тромбоэмболия легочной артерии: клинические рекомендации Европейского общества кардиологов (2014). По материалам: 2014 ESC Guidelines on the diagnosis andmanagement of acute pulmonary embolism – web addenda. The Task Force for the Diagnosis and Management. Пульмонология. 2015;25(5):525-552. https://doi.org/10.18093/0869-0189-2015-25-5-525-552
For citation:
article E. Pulmonary embolism: clinical guidelines of European Society of Cardiology (2014).The Task Force of the European Society of Cardiology for diagnosis and management of pulmonary embolism. PULMONOLOGIYA. 2015;25(5):525-552. (In Russ.) https://doi.org/10.18093/0869-0189-2015-25-5-525-552
Просмотров: 1119
Послать статью по эл. почте 